The landscape of drug discovery is poised for a significant transformation with the advent of VirtuDockDL, a groundbreaking Python-based platform driven by deep learning and graph neural networks (GNNs). Developed through a collaborative effort by researchers from The University of Lahore,
Stéphanie Gauvin and Tim MacIsaac, a devoted couple hailing from Nova Scotia, have embarked on a challenging and emotional journey to save their five-year-old golden doodle, Lucy, diagnosed with T-cell lymphoma. In their quest to find the best possible treatment for Lucy, they have encountered
Groundbreaking research, funded by Cancer Research UK and conducted by teams from the Cancer Research UK Scotland Institute in Glasgow and the University of Birmingham, has uncovered innovative ways to potentially use salmonella bacteria to combat bowel cancer. Historically known for causing food
Johnson & Johnson (J&J) has announced promising topline results from its Phase III ICONIC-LEAD trial evaluating icotrokinra (JNJ-2113) for the treatment of moderate to severe plaque psoriasis in patients aged 12 and older. The study revealed that 64.7% of participants treated with icotrokinra
The COVID-19 pandemic has brought unprecedented challenges to global health, but recent research suggests it may also offer unexpected benefits. Scientists from the Northwestern Medicine Canning Thoracic Institute have discovered a surprising link between the immune response to COVID-19 and cancer
In an ambitious move to drive cancer research forward, UNMC leadership alongside several community groups testified before the Nebraska Legislature’s Health and Human Services Committee to underscore the critical need for timely access to state cancer data. Dr. Joann Sweasy, director of the Fred &